Availability Notice Neutral

UBS AG - Publication of UBSs second-quarter 2026 results

Full analysis

What this filing means

UBS AG has published its second-quarter 2026 results on 29 July 2026 — that is the headline, but the SENS notice is an availability notice rather than a results announcement. The 11 South African-listed UBS instruments (UBS003, FNBOD1, UAADY1, etc.) carry no change to their terms since the September 2019 Information Memorandum, and the actual quarterly figures live on UBS's global investor-relations website. For a SENS reader, this is a heads-up, not a print: there are no metrics here to score against.

If you hold a UBS-listed note or certificate on the JSE, this notice tells you UBS has released its latest quarterly results and that nothing about your instrument's terms has changed since the 2019 paperwork. The actual numbers — earnings, capital, credit losses — are not in this announcement; you would need to fetch them from UBS's website. For most holders, the meaningful question is whether UBS itself remains healthy, and this notice does not answer that.

Bear case

  • The SENS release discloses publication only — no Q2 2026 financial metrics (revenue, CET1, credit losses) appear; SA holders must retrieve the report from UBS's global IR site.
  • The 'no material changes' affirmation references a September 2019 Information Memorandum, confirming structural terms only and not UBS's current credit profile for the listed ZA securities.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

A publication notice, not a print. The SENS release confirms UBS AG has published its Q2 2026 results and that the 11 ZA-listed instruments' terms are unchanged since the 2019 Information Memorandum — no figures, no guidance, no event in this notice itself. The Q2 numbers sit on UBS's global IR site, so there is nothing to score against the prior quarter. For ZA holders, the read is plain: nothing has changed on instrument terms today, and the issuer's credit standing — the live question — is not addressed here. So what: the next point of real information is the full Q2 2026 report, where the actual metrics live. Missing evidence: No financial results, ratios, or performance metrics disclosed in this SENS filing; No HEPS, EPS, revenue, or profit/loss figures provided; No dividend declaration or distribution information included; No forward guidance or outlook statement in the notice; No balance sheet, cash flow, or capital adequacy data for SA security holders; No qualitative description of Q2 2026 operating performance versus prior periods

The next point of real information is UBS's full Q2 2026 report, where the actual earnings and capital metrics live.

Evidence from the filing

  • The SENS release discloses publication only — no Q2 2026 financial metrics (revenue, CET1, credit losses) appear; SA holders must retrieve the report from UBS's global IR site.

    “UBS AG has published its second-quarter 2026 results”
  • The 'no material changes' affirmation references a September 2019 Information Memorandum, confirming structural terms only and not UBS's current credit profile for the listed ZA securities.

    “there have been no material changes to the terms and conditions of the South African Securities as described in the Information Memorandum dated 16 September 2019”
Category
Availability Notice
Published
Jul 29, 2026

Related filings